← Open Payments lookup

KAITLIN OLSON: Open Payments

NPI 1477096477 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,124 in 10 payments from 10 companies in 2025. Trend: 2023 $83 · 2024 $599 · 2025 $1,124

Food & beverage: $1,124
CompanyPaymentsAmount
Genmab U.S., Inc.1$125
SOBI, INC1$124
JAZZ PHARMACEUTICALS INC.1$123
Agios Pharmaceuticals, Inc.1$122
E.R. Squibb & Sons, L.L.C.1$116
AstraZeneca Pharmaceuticals LP1$112
GlaxoSmithKline, LLC.1$110
Merck Sharp & Dohme LLC1$105
Syndax Pharmaceuticals, Inc.1$99
Ipsen Biopharmaceuticals, Inc1$88

Products named: Tivdak, Vonjo, RYLAZE, PYRUKYND, OPDIVO, LYNPARZA, KEYTRUDA, REVUFORJ.

Industry payments across TX — which companies pay providers there.